Janus Henderson Group PLC grew its stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 52.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 29,730 shares of the company's stock after buying an additional 10,220 shares during the period. Janus Henderson Group PLC owned 0.32% of Semler Scientific worth $1,605,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of SMLR. BNP Paribas Financial Markets purchased a new stake in shares of Semler Scientific in the fourth quarter valued at $30,000. Jones Financial Companies Lllp purchased a new stake in shares of Semler Scientific in the fourth quarter valued at $34,000. Larson Financial Group LLC purchased a new stake in shares of Semler Scientific in the fourth quarter valued at $38,000. NewEdge Advisors LLC grew its position in shares of Semler Scientific by 318.3% in the fourth quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock valued at $40,000 after purchasing an additional 557 shares during the period. Finally, IFP Advisors Inc purchased a new stake in shares of Semler Scientific in the fourth quarter valued at $54,000. Hedge funds and other institutional investors own 49.37% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen downgraded Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd.
View Our Latest Stock Report on Semler Scientific
Semler Scientific Price Performance
SMLR stock traded down $0.93 during trading on Tuesday, reaching $43.39. 1,078,623 shares of the stock traded hands, compared to its average volume of 495,379. The business's 50 day moving average price is $36.17 and its 200-day moving average price is $47.22. The firm has a market capitalization of $483.89 million, a PE ratio of 8.84 and a beta of 1.33. Semler Scientific, Inc. has a 52-week low of $21.77 and a 52-week high of $81.56.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.76) EPS for the quarter. The company had revenue of $8.84 million for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.
About Semler Scientific
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
